FindTrial
Sign In

Clinical study to evaluate the efficacy of COMPOUND UNANI FORMULATION JAWARISH-E-TABASHEER in GERD

A RANDOMISED TWO ARM ACTIVE CONTROLLED CLINICAL STUDY OF GASTRO ESOPHAGEAL REFLUX DISEASE (MARZ-E-INEKAS-E-HUMUZAT-E-MEDA WO MARI ) WITH COMPOUND UNANI FORMULATION JAWARISH-E-TABASHEER AND RABEPRAZOLE - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/096779
Enrollment
40
Registered
2025-11-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system

Interventions

Intervention1: JAWARISH E TABSHEER: 5GMS BD WITH ARQ BADYAN 150ML AFTER MEALS WITH TWO FOLLOW UPS WITH INTERVAL OF 15 DAYS Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Nil: Nil Inte

Sponsors

PG Scholar Dept of Moalijat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient of either sex Age : 20-60 years. Patient with following complains :Regurgitation, Heart burn, Epigastric Pain,Nausea ,Indigestion,Flatulence,Loss of appetite, Water brash, Heaviness in abdomen after meals.

Exclusion criteria

Exclusion criteria: Pregnant and lactating women Psychiatric patients Uncontrolled diabetes GERD due to LOS causes . Patients with cardiac, respiratory, liver and renal dysfunction. Patients with: Bleeding disorders Known peptic ulcers Gastric carcinoma Hiatus hernia Crohn’s disease Zollinger Ellison Syndrome Esophageal strictures, stenosis Other malignancies

Design outcomes

Primary

MeasureTime frame
to evaluate the clinical efficacy of jawarish e tabasheer in cases of GERDTimepoint: once in 2-4 weeks—

Secondary

MeasureTime frame
To prevent from complications of GERD like peptic strictures, Barret’s esophagus, esophageal adenocarcinoma.Timepoint: Once in Two weeks—

Countries

India

Contacts

Public ContactDr Amreen

Government Nizamia Tibbi College and Hospital

drsakhussaini@gmail.com9704888561

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026